The edition · Psychiatry
Caring letters after a crisis call did not lower suicide deaths in 227,502 US veterans
A prespecified analysis found no difference in suicide mortality with or without letters. Also: depression in four of ten people with drug-resistant tuberculosis, a relapse model where clinical history beat brain scans and genetics, and what perinatal 'brain fog' does and does not show.
The edition in brief
Today's psychiatry edition leads on suicide prevention. A prespecified secondary analysis in JAMA Psychiatry of the US Veterans Crisis Line caring letters programme found suicide mortality at 12 months of 0.29% among 87,926 veterans who received letters and 0.27% among 139,576 historical controls (P = .31); peer and clinician signatories did no differently. The letters-versus-none comparison was observational. A PLOS One meta-analysis of 23 studies in low- and lower-middle-income countries found depression in 41.9% of 5734 people with multidrug-resistant tuberculosis, with stigma, comorbidity and drug side effects among the strongest correlates. A German prognostic study of 564 people with major depression found machine-learning models predicted two-year relapse with balanced accuracy of at most 64%, and the best model used only a few clinical risk factors; imaging, genetics, blood markers and microbiome added nothing. A review of 42 studies found perinatal depressive symptoms consistently linked to self-reported cognitive complaints but not reliably to objective test performance. On the regulatory side, the FDA recorded a supplement to an existing generic olanzapine application held by an Indian manufacturer, an administrative action rather than a safety finding. The pearl covers how stopping smoking raises clozapine and olanzapine levels.
Four in ten people with drug-resistant TB are depressed
Build depression screening into care for every patient on treatment for drug-resistant tuberculosis.
Predicting depressive relapse: brain scans and genetics added nothing to clinical history
Rely on clinical history, not biomarkers, when judging an individual's risk of depressive relapse.
FDA records a supplement to a generic olanzapine application
No change to practice: this is a routine supplement to an existing generic olanzapine licence.
Perinatal 'brain fog': linked to depression in self-report, not clearly on testing
Treat a perinatal complaint of poor memory as a prompt to screen for depression.
When a patient on clozapine or olanzapine stops smoking, levels rise
Check clozapine levels and review the dose whenever a patient stops or restarts smoking.
Caring letters after a crisis call: no difference in suicide deaths
Treat caring letters as an add-on, not a substitute, for direct follow-up after a suicidal crisis.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for psychiatry, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free